In conclusion, BIBF inhibits autophagy and promotes the accumulation of toxic substances in glioblastoma, leading to the onset of apoptosis by decreasing the expression levels of LAMP1, LAMP2, and Rab7 while impairing lysosomal function and its ability to fuse with autophagosomes. The gene discussed is LAMP2; the disease is glioblastoma.